Home › Funds › SNYDER CAPITAL MANAGEMENT L P › CRL

SNYDER CAPITAL MANAGEMENT L P position in CRL

CHARLES RIV LABS INTL INC · Health Care

SNYDER CAPITAL MANAGEMENT L P reported holding 272,635 shares of CRL (CHARLES RIV LABS INTL INC) in its Q3 2026 13F filing — a position valued at US$80.4M, representing 1.58% of its reported portfolio and ranking #23 among its reported holdings. SNYDER CAPITAL MANAGEMENT L P has disclosed CRL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)272.63K sh
Reported value held$80.43M
Portfolio Weight1.58%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How SNYDER CAPITAL MANAGEMENT L P's CRL position evolved

SNYDER CAPITAL MANAGEMENT L P first disclosed a stake in CRL in Q3 2023 at 154,834 shares (US$30.3M). The position peaked in Q3 2026 at 272,635 shares, worth US$80.4M. Across 13 filings, SNYDER CAPITAL MANAGEMENT L P increased the stake 5 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 272,635 shares valued at US$80.4M — a reduction of -9,121 shares quarter over quarter.. Notable position changes include a 35% increase in Q4 2025 (shares fell 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 154.83K $30.34M New
Q4 2023 147.34K $34.83M Reduce
Q1 2024 138.15K $37.43M Reduce
Q2 2024 135.64K $28.02M Reduce
Q3 2024 153.84K $30.30M Add
Q4 2024 177.93K $32.85M Add
Q1 2025 174.26K $26.23M Reduce
Q2 2025 181.11K $27.48M Add
Q3 2025 177.91K $27.84M Reduce
Q4 2025 240.96K $48.07M Add
Q1 2026 237.71K $41.00M Reduce
Q2 2026 281.76K $63.90M Add
Q3 2026 272.63K $80.43M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRL and 13F data

CRL (CHARLES RIV LABS INTL INC) is a Health Care company. 31 other funds we track also report a position in CRL — the largest reported positions include ARIEL INVESTMENTS, LLC (US$352.0M), EARNEST PARTNERS LLC (US$320.7M), Allspring Global Investments Holdings, LLC (US$254.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRL

All CRL fund holders →

FAQ

How long has SNYDER CAPITAL MANAGEMENT L P held CRL?

SNYDER CAPITAL MANAGEMENT L P has disclosed CRL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is SNYDER CAPITAL MANAGEMENT L P's current position in CRL?

As of Q3 2026, SNYDER CAPITAL MANAGEMENT L P holds 272.63K shares of CRL (CHARLES RIV LABS INTL INC), valued at $80.43M, representing 1.58% of its reported portfolio and ranking #23.

Has SNYDER CAPITAL MANAGEMENT L P been buying or selling CRL?

In the latest 13F filing (Q3 2026), SNYDER CAPITAL MANAGEMENT L P reduced its position in CRL. The position peaked in Q3 2026 at 272.63K shares.

Which other funds hold CRL?

Other major institutional holders of CRL include ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, Allspring Global Investments Holdings, LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.